Statins (HMGCR blockers), lonafarnib (farnesyltransferase inhibitors), the anti-inflammatory drug aspirin, and the anti-malarial drug adiponectin all have a therapeutic role in ovarian cancer. Here, ADIPOQ is linked to ovarian carcinoma.